IOBT: IO Biotech, Inc. Stock

by  •  • Comments Off on IOBT: IO Biotech, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 93.55
Enterprise Value ($M) -49.64
Book Value ($M) 133.16
Book Value / Share 2.02
Price / Book 0.70
NCAV ($M) 129.70
NCAV / Share 1.97
Price / NCAV 0.72

Profitability (mra)
Return on Invested Capital (ROIC) -0.63
Return on Assets (ROA) -0.63
Return on Equity (ROE) -0.69

Liquidity (mrq)
Quick Ratio 9.37
Current Ratio 9.37

Balance Sheet (mrq) ($M)
Current Assets 147.25
Assets 150.72
Liabilities 17.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -91.44
Net Income -86.08
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -71.74
Cash from Investing -0.32
Cash from Financing 71.86

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Avoro Capital Advisors LLC 0.00 -100.00
02-13 13G/A Bank Of America Corp /de/ 2.80 -0.54
02-13 13G/A Stonepine Capital Management, LLC 5.40 -7.83
02-13 13D/A Novo Holdings A/S 11.10 -8.02
02-13 13G/A HBM Healthcare Investments (Cayman) Ltd. 6.00 -28.59
12-18 13G Samsara BioCapital, L.P. 5.50
09-07 13G Kurma Partners 17.18
08-14 13D/A Lundbeckfond Invest A/S 29.60 261.22

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-22 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ T
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 3,774 36,178 10.43
2024-04-25 1,769 25,579 6.92
2024-04-24 11,086 34,656 31.99
2024-04-23 18,267 21,766 83.92

(click for more detail)

Similar Companies
INSM – Insmed Incorporated INVA – Innoviva, Inc.
INZY – Inozyme Pharma, Inc. IONS – Ionis Pharmaceuticals, Inc.
IPSC – Century Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io